Allurion to Report Fourth Quarter 2023 Financial Results on March 21, 2024

Rhea-AI Summary

Allurion Technologies, Inc. (ALUR) will report Q4 2023 financial results on March 21, 2024. A conference call will follow to discuss results and provide a business update.

NATICK, Mass.--(BUSINESS WIRE)-- Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced that it will report financial results for the fourth quarter 2023 on Thursday, March 21, 2024. Company management will host a conference call to discuss financial results and provide a business update on the same day at 8:30 AM ET.

To access the conference call by telephone, please dial (888) 330-3417 (domestic) or +1 646 960 0804 (international) and use Conference ID 1905455. To listen to the conference call via live audio webcast, please visit the Events section of Allurion’s Investor Relations website at Allurion - Events & Presentations.

A replay of the conference call will be available by telephone by dialing (800) 770 2030 (domestic) or +1 647 362 9199 (international) and using Access Code 1905455. The archived webcast will also be available on Allurion’s Investor Relations website mentioned above.

About Allurion

Allurion is dedicated to ending obesity. The Allurion Program is a weight loss platform that features the Allurion Gastric Balloon, the world’s first and only swallowable, procedure-less intragastric balloon for weight loss, and offers access to the Allurion Virtual Care Suite including the Allurion Mobile App for consumers, Allurion Insights for health care providers featuring the Iris AI Platform, and the Allurion Connected Scale. The Allurion Virtual Care Suite is also available to providers separately from the Allurion Program to help customize, monitor and manage weight loss therapy for patients regardless of their treatment plan: gastric balloon, surgical, medical or nutritional. The Allurion Gastric Balloon is an investigational device in the United States.

For more information about Allurion and the Allurion Virtual Care Suite, please visit www.allurion.com.

Allurion is a trademark of Allurion Technologies, Inc. in the United States and countries around the world.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240304073536/en/

Global Media

Cedric Damour

PR Manager

+33 7 84 21 02 20

cdamour@allurion.com



Investors

Hannah Lindberg

hlindberg@allurion.com

Source: Allurion Technologies, Inc.

FAQ

When will Allurion Technologies, Inc. report financial results for Q4 2023?

Allurion Technologies, Inc. (ALUR) will report financial results for the fourth quarter of 2023 on Thursday, March 21, 2024.

What time will the conference call to discuss financial results be held on March 21, 2024?

The conference call to discuss financial results and provide a business update will be held at 8:30 AM ET on March 21, 2024.

How can I access the conference call by telephone?

To access the conference call by telephone, please dial (888) 330-3417 (domestic) or +1 646 960 0804 (international) and use Conference ID 1905455.

Where can I listen to the conference call via live audio webcast?

You can listen to the conference call via live audio webcast by visiting the Events section of Allurion’s Investor Relations website at Allurion - Events & Presentations.

How can I access the replay of the conference call?

To access the replay of the conference call by telephone, dial (800) 770 2030 (domestic) or +1 647 362 9199 (international) and use Access Code 1905455. The archived webcast will also be available on Allurion’s Investor Relations website.